Targeting S1P Receptors, A New Mechanism of Action for Inflammatory Bowel Disease Therapy.
Academic Department of Gastroenterology, Laikon Hospital, Athens, Greece.
Giorgos
G
Bamias
IBD Center, University of California San Diego, San Diego, California.
Jesus
J
Rivera-Nieves